All News Patrys Limited

Equities

PAB

AU000000PAB9

Delayed Australian S.E. Other stock markets 09:36:55 21/06/2024 am IST			5-day change	1st Jan Change
0.007 ^AUD	-12.50%		-12.50%	-12.50%

10/04	Patrys Reports 'Positive' Results for Deoxymabs in Autoimmune Vasculitis Treatment	MT
23/02	Patrys Limited Reports Earnings Results for the Half Year Ended December 31, 2023	CI

All News

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Patrys Reports 'Positive' Results for Deoxymabs in Autoimmune Vasculitis Treatment	10/04	MT
Patrys Limited Reports Earnings Results for the Half Year Ended December 31, 2023	23/02	CI
Patrys to Begin Production of PAT-DX1 in Q1 2024	13/12	MT
Patrys Limited Announces Retirement of Suzy Jones as Director	14/23/14	CI
Patrys Limited Reports Earnings Results for the Full Year Ended June 30, 2023	28/23/28	CI
Patrys Reports 'Favorable' Results from Pre-Clinical Study of Cancer Therapy	24/23/24	MT
US Patent Office Grants Patrys Two New Deoxymab Patents	18/23/18	MT
Patrys secures US patents for antibody technology	18/23/18	AQ
Patrys Moves Phase One Trial for Brain Cancer Drug to 2024; Shares Tumble 24%	31/23/31	MT
Patrys Limited Announces New PAT-DX3 Data Demonstrates Synthetic Lethality	14/23/14	CI
Patrys Limited Reports Earnings Results for the Half Year Ended December 31, 2022	24/23/24	CI
Patrys Unit Secures AU$3 Million R&D Tax Refund	30/23/30	MT
Patrys : Insights Care Magazine \| Interview with Dr James Campbell	30/22/30	PU
Patrys Appoints Global Biotechnology Leader as Chairman - In Preparation for First Clinical Trial for Groundbreaking Cancer Therapy	18/22/18	BU
Patrys Names Chairman	16/22/16	MT
Patrys Limited Appoints Charmaine Gittleson as the Chairman of the Board of Directors, Effective November 16, 2022	16/22/16	CI
Patrys : INTERVIEW \| Dr James Campbell on Proactive	17/22/17	PU
Patrys Limited Announces New Preclinical Data for its Full-Sized IgG Antibody, Pat-DX3	17/22/17	CI
Patrys Limited Announces Appointment of Mr. Stefan Ross as Non-Executive Director	31/22/31	CI
Patrys Limited Reports Earnings Results for the Full Year Ended June 30, 2022	30/22/30	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News Patrys Limited

Equities

PAB

AU000000PAB9

All News

Filters